共 100 条
[1]
Adam MP(2011)Evolving knowledge of the teratogenicity of medications in human pregnancy American Journal of Medical Genetics Part C, Seminars in Medical Genetics 157 175-182
[2]
Polifka JE(2005)Medication use during pregnancy and lactation: An urgent call for public health action Journal of Women’s Health 14 104-109
[3]
Friedman JM(2002)Teratogenicity of recently introduced medications in human pregnancy Obstetrics and Gynecology 100 465-473
[4]
Lagoy CT(2003)Systematic identification of drugs that cause birth defects—A new opportunity The New England Journal of Medicine 349 2556-2559
[5]
Joshi N(2013)Medications in the first trimester of pregnancy: Most common exposures and critical gaps in understanding fetal risk Pharmacoepidemiology and Drug Safety 22 1013-1018
[6]
Cragan JD(2011)Nationwide register-based surveillance system on drugs and pregnancy in Finland 1996–2006 Pharmacoepidemiology and Drug Safety 20 729-738
[7]
Lo WY(2006)Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands BJOG 113 559-568
[8]
Friedman JM(2011)Use of prescribed drugs among primiparous women: An 11-year population-based study in Denmark Clinical Epidemiology 3 149-156
[9]
Mitchell AA(2011)Prescription drug use during pregnancy in developed countries: A systematic review Pharmacoepidemiology and Drug Safety 20 895-902
[10]
Thorpe PG(2011)Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database Pharmacoepidemiology and Drug Safety 20 243-248